EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Transcription factor EGR2 alleviates autoimmune uveitis via activation of GDF15 to modulate the retinal microglial phenotype

Wanqian Li, Siyuan He, Jun Tan, Na Li, Chenyang Zhao, Xiaotang Wang, Zhi Zhang, Jiangyi Liu, Jiaxing Huang, Xingran Li, Qian Zhou, Ke Hu und 2 weitere

Proceedings of the National Academy of Sciences · 2024

DOI: 10.1073/pnas.2316161121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Wanqian Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, Chongqing Branch (…. Hauptthemen laut MEDLINE: Autoimmune Diseases, Early Growth Response Protein 2, Growth Differentiation Factor 15, Microglia. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation Project of China, Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes, Chongqing Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Uveitis is a vision-threatening disease primarily driven by a dysregulated immune response, with retinal microglia playing a pivotal role in its progression. Although the transcription factor EGR2 is known to be closely associated with uveitis, including Vogt–Koyanagi–Harada disease and Behcet’s disease, and is essential for maintaining the dynamic homeostasis of autoimmunity, its exact role in uveitis remains unclear. In this study, diminished EGR2 expression was observed in both retinal microglia from experimental autoimmune uveitis (EAU) mice and inflammation-induced human microglia cell line (HMC3). We constructed a mice model with conditional knockout of EGR2 in microglia and found that EGR2 deficiency resulted in increased intraocular inflammation. Meanwhile, EGR2 overexpression downregulated the expression of inflammatory cytokines as well as cell migration and proliferation in HMC3 cells. Next, RNA sequencing and ChIP-PCR results indicated that EGR2 directly bound to its downstream target growth differentiation factor 15 (GDF15) and further regulated GDF15 transcription. Furthermore, intravitreal injection of GDF15 recombinant protein was shown to ameliorate EAU progression in vivo. Meanwhile, knockdown of GDF15 reversed the phenotype of EGR2 overexpression–induced microglial inflammation in vitro. In summary, this study highlighted the protective role of the transcription factor EGR2 in AU by modulating the microglial phenotype. GFD15 was identified as a downstream target of EGR2, providing a unique target for uveitis treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune DiseasesEarly Growth Response Protein 2Growth Differentiation Factor 15MicrogliaUveitisAnimalsHumansMiceCell LineDisease Models, AnimalMice, Inbred C57BLMice, KnockoutPhenotypeRetina

Stichwörter der Autor:innen

EGR2GDF15autoimmune uveitismicroglia

Substanzen

Early Growth Response Protein 2Egr2 protein, mouseGdf15 protein, mouseGrowth Differentiation Factor 15GDF15 protein, humanEGR2 protein, human

Autor:innen und Institutionen

  • The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, Chongqing Branch (Municipality Division) of National Clinical Research Center for Ocular…
  • Department of Laboratory Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing 100005, China.
  • Department of Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.

ORCID-Profile: Shengping Hou

Förderung

  • National Natural Science Foundation Project of China
  • Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes
  • Chongqing Natural Science Foundation
  • Program for Youth Innovation in Future Medicine, Chongqing Medical University

Zitieren

APA

Li, W., He, S., Tan, J., Li, N., Zhao, C., Wang, X., Zhang, Z., Liu, J., Huang, J., Li, X., Zhou, Q., Hu, K., Yang, P., & Hou, S. (2024). Transcription factor EGR2 alleviates autoimmune uveitis via activation of GDF15 to modulate the retinal microglial phenotype. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2316161121

Vancouver

Li W, He S, Tan J, Li N, Zhao C, Wang X, et al. Transcription factor EGR2 alleviates autoimmune uveitis via activation of GDF15 to modulate the retinal microglial phenotype. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2316161121

BibTeX
@article{Li2024,
  author = {Li, Wanqian and He, Siyuan and Tan, Jun and Li, Na and Zhao, Chenyang and Wang, Xiaotang and Zhang, Zhi and Liu, Jiangyi and Huang, Jiaxing and Li, Xingran and Zhou, Qian and Hu, Ke and Yang, Peizeng and Hou, Shengping},
  title = {Transcription factor EGR2 alleviates autoimmune uveitis via activation of GDF15 to modulate the retinal microglial phenotype},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  doi = {10.1073/pnas.2316161121}
}
Kostenlos starten →